China Botanic Pharmaceutical Inc  

(Public, OTCMKTS:CBPI)   Watch this stock  
Find more results for NYSEAMEX:CBP
0.00000 (0.00%)
Nov 12 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.00 - 0.01
Open     -
Vol / Avg. 0.00/437.00
Mkt cap 37,240.00
P/E 0.00
Div/yield     -
EPS 0.77
Shares 37.24M
Beta     -
Inst. own 0%

Key stats and ratios

Q3 (Jul '12) 2011
Net profit margin 21.59% 35.65%
Operating margin 25.12% 40.60%
EBITD margin - 41.91%
Return on average assets 10.04% 28.32%
Return on average equity 10.68% 30.60%
Employees 666 -
CDP Score - -


Level11,Changjiang International Bldg. No.28, Changjiang Road, Nangang District
+86-451-57620378 (Phone)
+86-451-57620378 (Fax)

Website links


China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacture and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines (TCM), in the People’s Republic of China. As of October 31, 2011, it had three production facilities: Ah City Natural and Biopharmaceutical plant, Dongfanghong pharmaceutical plant and Qingyang natural extraction plant, capable of producing 18 dosage forms and over 200 different products. The Company’s products include botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and traditional over-the-counter (OTC) Chinese medicines. During the fiscal year ended October 31, 2011 (fiscal 2011), botanical anti-depression and nerve-regulation products accounted for approximately 70% of its revenues.

Officers and directors

Shaoming Li Chairman of the Board, President, Chief Executive Officer
Age: 50
Weiqiu Dong Chief Financial Officer
Age: 42
Jiang He Secretary
Age: 41
Dianjun Pi Director
Age: 56
Changxiong Sun Independent Director
Age: 67
Bingchun Wu Independent Director
Age: 79
Jack Zhao Independent Director
Age: 31